dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate

C53H66BCl2IK2N16O7 — CID 158520819

IUPACdipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate
SMILESCC(=O)N1CCn2c(C3CC3)nc(-c3cnc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CC(=O)N1CCn2c(C3CC3)nc(I)c2C1.CC(Cl)Cl.Cn1cc(-c2nn(C)c3ncc(B4OC(C)(C)C(C)(C)O4)cc23)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C22H24N8O.C17H22BN5O2.C11H14IN3O.C2H4Cl2.CH2O3.2K.H/c1-13(31)29-6-7-30-18(12-29)20(25-21(30)14-4-5-14)15-8-17-19(16-10-24-27(2)11-16)26-28(3)22(17)23-9-15;1-16(2)17(3,4)25-18(24-16)12-7-13-14(11-8-20-22(5)10-11)21-23(6)15(13)19-9-12;1-7(16)14-4-5-15-9(6-14)10(12)13-11(15)8-2-3-8;1-2(3)4;2-1-4-3;;;/h8-11,14H,4-7,12H2,1-3H3;7-10H,1-6H3;8H,2-6H2,1H3;2H,1H3;1,3H;;;/q;;;;;2*+1;-1/p-1
InChIKeyVIYTXRGRQYPXPR-UHFFFAOYSA-M
MW1326.03 g/mol
LogP0.23
Rot. Bonds7

About dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate

dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate (PubChem CID 158520819) has the molecular formula C53H66BCl2IK2N16O7 and a molecular weight of 1326.03 g/mol. Its IUPAC name is dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate.

Molecular Properties

Compound Namedipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate
PubChem CID158520819
Molecular FormulaC53H66BCl2IK2N16O7
Molecular Weight1326.03 g/mol
Exact Mass1324.31
IUPAC Namedipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate
SMILESCC(=O)N1CCn2c(C3CC3)nc(-c3cnc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CC(=O)N1CCn2c(C3CC3)nc(I)c2C1.CC(Cl)Cl.Cn1cc(-c2nn(C)c3ncc(B4OC(C)(C)C(C)(C)O4)cc23)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C22H24N8O.C17H22BN5O2.C11H14IN3O.C2H4Cl2.CH2O3.2K.H/c1-13(31)29-6-7-30-18(12-29)20(25-21(30)14-4-5-14)15-8-17-19(16-10-24-27(2)11-16)26-28(3)22(17)23-9-15;1-16(2)17(3,4)25-18(24-16)12-7-13-14(11-8-20-22(5)10-11)21-23(6)15(13)19-9-12;1-7(16)14-4-5-15-9(6-14)10(12)13-11(15)8-2-3-8;1-2(3)4;2-1-4-3;;;/h8-11,14H,4-7,12H2,1-3H3;7-10H,1-6H3;8H,2-6H2,1H3;2H,1H3;1,3H;;;/q;;;;;2*+1;-1/p-1
InChIKeyVIYTXRGRQYPXPR-UHFFFAOYSA-M
XLogP0.23
TPSA241.14 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds7
Heavy Atoms82
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001326.03
LogP ≤ 50.23
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate?
The IUPAC name of dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate (CID 158520819) is dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate.
What is the SMILES notation for dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate?
The canonical SMILES for dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate is CC(=O)N1CCn2c(C3CC3)nc(-c3cnc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CC(=O)N1CCn2c(C3CC3)nc(I)c2C1.CC(Cl)Cl.Cn1cc(-c2nn(C)c3ncc(B4OC(C)(C)C(C)(C)O4)cc23)cn1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate?
The InChIKey is VIYTXRGRQYPXPR-UHFFFAOYSA-M. The full InChI is InChI=1S/C22H24N8O.C17H22BN5O2.C11H14IN3O.C2H4Cl2.CH2O3.2K.H/c1-13(31)29-6-7-30-18(12-29)20(25-21(30)14-4-5-14)15-8-17-19(16-10-24-27(2)11-16)26-28(3)22(17)23-9-15;1-16(2)17(3,4)25-18(24-16)12-7-13-14(11-8-20-22(5)10-11)21-23(6)15(13)19-9-12;1-7(16)14-4-5-15-9(6-14)10(12)13-11(15)8-2-3-8;1-2(3)4;2-1-4-3;;;/h8-11,14H,4-7,12H2,1-3H3;7-10H,1-6H3;8H,2-6H2,1H3;2H,1H3;1,3H;;;/q;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate?
dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate has a molecular weight of 1326.03 g/mol, XLogP of 0.23, 7 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-(3-cyclopropyl-1-iodo-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)ethanone;1-[3-cyclopropyl-1-[1-methyl-3-(1-methylpyrazol-4-yl)pyrazolo[5,4-b]pyridin-5-yl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]ethanone;1,1-dichloroethane;hydride;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine;oxido formate is sourced from PubChem (CID 158520819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).